chronic kidney disease

News

AstraZeneca extends use of ImpediMed digital tool in CKD tri...

AstraZeneca has extended a contract to use a digital health device developed by ImpediMed that is being deployed in a trial of two of its drugs in chronic kidney disease (CKD).

News

GSK shelves arthritis blockbuster hope otilimab after lacklu...

GSK has said it will not be able to move ahead with regulatory filings for otilimab as a treatment for rheumatoid arthritis (RA), after it failed to show the desired level of efficacy in tw

News

Cells and biological chain,molecules and abstract conception,3d rendering. Computer digital drawing.

AZ/BenevolentAI collab achieves AI-enabled further milestone...

Two additional novel AI-generated targets for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF) have been discovered using the Benevolent Platform and selected for AstraZ

News

GSK's daprodustat will have to face FDA advisory committee

GSK has said that its daprodustat for anaemia associated with chronic kidney disease (CKD) will have to face an FDA advisory committee before the US regulator delivers a verdict on the drug

News

Ionis antithrombotic with reduced bleed risk clears phase 2b...

Patients with end-stage renal disease (ESRD) who are on dialysis often need to be treated with anticoagulants to prevent blood clots, but as a result, can experience bleeding side effects.

News